Fluid Therapy

1. PERIOPERATIVE FLUID
THERAPY
Dr. Reem Alsafar
Anesthesia consultant

2. Lecture Objectives
Students at the end of the lecture will be able
to:
 To estimate the perioperative fluid requirement and to prescribe
/calculate fluid therapy.
 Identify perioperative factors affect the patient fluid requirements
 To detect the common conditions associated with preoperative fluids
deficit
 To assess a patient with a volume deficit
 -Describe different fluids components and illustrate the advantages and
disadvantages of each type.
 Recognize the different types of blood and blood products and to discuss the
indications of each type and complications.

3. physiology
Total Body Water (TBW)
• Varies with age, gender
• The 70 kg 'standard male' contains 42L
60% body weight in males
• 50% body weight in females
• 80% body weight in new born
• Less in obese: fat contains little water

4. Body Water Compartments
• Intracellular water: 2/3 of TBW
• Extracellular water: 1/3 TBW
- Extravascular water: 3/4 of extracellular water
- Intravascular water: 1/4 of extracellular water

6. Electrolyte physiology:
• Primary ECF cation is Na
Very small contribution of K , Ca 2+ , and Mg 2+
• Primary ICF cation is K
Smaller contribution from Mg 2+ & Na

7. Physiology
Fluid and Electrolyte Regulation
• Volume Regulation
- Antidiuretic Hormone
- Renin/angiotensin/aldosterone system
- Baroreceptors in carotid arteries and aorta
- Stretch receptors in atrium and juxtaglomerular
aparatus
- Cortisol

8. Physiology
Fluid and Electrolyte Regulation
• Plasma Osmolality Regulation
- Arginine-Vasopressin (ADH)
- Central and Peripheral osmoreceptors
• Sodium Concentration Regulation
- Renin/angiotensin/aldosterone system
- Macula Densa of JG apparatus

9. The aim of maintenance of fluid,
electrolytes, acid base balance and
blood volume
The final goal is delivery of adequate oxygen to
the tissues.
Factors affecting oxygen delivery equation includes:
 cardiac output (= stroke volume × heart rate);
 haemoglobin concentration;
 oxygen saturation

10. Desirable outcome of fluid
resuscitation
-No peripheral edema
-No ARDS

11. Assessment
of Fluid Status
- Input and output chart
- blood pressure: supine and standing
- heart rate
- skin turgor and capillary refill
- urinary output
- serum electrolytes/osmolarity
- mental status
- CVP (normal 4-8 mmHg)

12. Perioperative Fluid Requirements
The following factors must be taken into account:
1- Maintenance fluid requirements
2- NPO and other deficits: NG suction, bowel prep
3- Third space losses
4- Replacement of blood loss
5- Special additional losses: diarrhea

13. 1- Maintenance Fluid Requirements
• Insensible losses such as evaporation of water from
respiratory tract, sweat, feces, urinary excretion.
Occurs continually.
• “4-2-1 Rule”
- 4 ml/kg/hr for the first 10 kg of body weight
- 2 ml/kg/hr for the second 10 kg body weight
- 1 ml/kg/hr subsequent kg body weight
- Extra fluid for fever, tracheotomy, denuded surfaces

14. 2- NPO and other deficits
• NPO deficit = number of hours NPO x
maintenance fluid requirement.
• Bowel prep may result in up to 1 L fluid loss.
• Measurable fluid losses, e.g. NG suctioning,
vomiting, ostomy output, biliary fistula and tube.

15. 3- Third Space Losses
• Isotonic transfer of ECF from functional body
fluid compartments to non-functional
compartments.
• Depends on location and duration of surgical
procedure, amount of tissue trauma, ambient
temperature, room ventilation.

16. Replacing Third Space Losses
• Superficial surgical trauma: 1-2 ml/kg/hr
• Minimal Surgical Trauma: 3-4 ml/kg/hr
- head and neck, hernia, knee surgery
• Moderate Surgical Trauma: 5-6 ml/kg/hr
- hysterectomy, chest surgery
• Severe surgical trauma: 8-10 ml/kg/hr (or more)
- AAA repair, nephrectomy
N.B Recent studies recommends restrictive fluid therapy
(avoiding over loud/zero balanced therapy))

17. 4- Blood Loss
• Each 1cc of blood loss is replaced by 3 cc of
crystalloid solution (crystalloid solutions leave
the intravascular space)
• When using blood products or colloids replace
blood loss volume per volume

18. 5- Other additional losses
• Ongoing fluid losses from other sites:
- gastric drainage
- ostomy output
- diarrhea
• Replace volume per volume with crystalloid
solutions

19. Example
• 62 y/o male, 70 kg, for laparotomy bowel
resection (hemicolectomy)
• NPO after 2200, surgery at 0800, received bowel
prep
• 3 hr. procedure, 500 cc blood loss
• What are his estimated intraoperative fluid
requirements?

20. Example (cont.)
• Maintenance: 110 x 3hrs = 330mls
• Fluid deficit (NPO): 110 x 10 hrs = 1100 ml + 1000 ml
for bowel prep = 2100 ml total deficit: (Replace 1/2 first
hr, 1/4 2nd hr, 1/4 3rd hour).
• Third Space Losses: 6 ml/kg/hr x 3 hrs = 1260 mls
• Blood Loss: 500ml x 3 = 1500ml
• Total = 330 +2100+1260+1500=5190mls

21. Intravenous Fluids:
• Conventional Crystalloids
• Colloids
• Hypertonic Solutions
• Blood/blood products and blood substitutes

22. Crystalloids
• Combination of water and electrolytes
- Isotonic salt solution:
electrolyte composition and osmolality similar to
plasma; example: normal saline. (Balanced salt
solution): lactated Ringer’s, Plasmlyte, Normosol.
- Hypotonic salt solution:
electrolyte composition lower than that of plasma;
example: D5W. Half normal saline.
- Hypertonic salt solution:
2.7% NaCl.

23. Crystalloid solutions
Normal saline
0.9 %NaCl
Composistion: Isotonic 0.9%: 9g/l ,
Na 154, Cl 154.
Osmolarity: 304mosmol/l
Disadvantages: Hyper-chloremic acidosis

24. Crystalloids
Lactated Ringer's
Composition: Na 130, cl 109, K 4, ca 3, Lactate 28.
Osmolarity 273mosmol/l
-Sydney Ringer 1880
-Hartmann added Lactate=LR
-Minor advantage over NaCl
Disadvantages:
-Not to be used as diluent for blood (Ca citrate)
-Low osmolarity, can lead to high ICP
- Caution in kidney failure, in brain injury, high blood
sugar.

25. Crystalloids in trauma
Advantages:
-Balanced electrolyte solutions
-Buffering capacity (Lactate)
-Easy to administer
-No risk of adverse reactions
-No disturbance of hemostasis
-Promote diuresis
-Inexpensive

26. Hypertonic Solutions
• Fluids containing sodium concentrations greater than
normal saline.
• Available in 1.8%, 2.7%, 3%, 5%, 7.5%, 10% solutions.
• Hyperosmolarity creates a gradient that draws water out
of cells; therefore, cellular dehydration is a potential
problem.

27. Hypertonic saline
Advantages:
-Small volume for resuscitation.
-Osmotic effect
-Inotropic effect ( increase calcium influx in sarculima )
-Increase MAP, CO
-Increase renal, mesenteric,splanchnic, coronary blood
flow.

28. Hypertonic saline
Disadvantages:
• increase hemorrhage from open vessels.
• Hypernatremia
• Hyperchloremia.
• Metabolic acidosis.

29. Crystalloids
Dextrose 5%water
Composition: 50g/l.
Osmolality : 253
Disadvantages:
-enhance CO2 production
-enhance lactate production
-aggravate ischemic brain injury

30. Colloids
• Fluids containing molecules sufficiently large
enough to prevent transfer across capillary
membranes.
• Solutions stay in the space into which they are
infused (remain intravascular).
• Examples: hetastarch (Hespan), albumin, dextran.

31. Colloids
Advantages:
-Prolonged plasma volume support
-Moderate volume needed
-minimal risk of tissue edema
-enhances microvascular flow

32. Colloids
Disadvantages:
Risk of volume overload
Adverse effect on hemostasis
Adverse effect on renal function
Anaphylactic reaction
Expensive

33. Colloids
Dextran: Inhibit platelet aggregation -Bleeding
Gelatins
Albumins
Hetastarch 6%: synthetic, 6% preparation in isotonic saline MW
240,000 D, Disadvantages: Hyperamylesemia, allergy, coagulopathy. Dose
20ml/kg/day.
Pentastarch 10% MW: 200,000 D- DS 0.5, Low cost, Extensive
clinical use in sepsis, burns. Potential to diminish vascular permeability and
reduces tissue edema
Tetrastarch (Voluven):
MW 130,000 D, Used for volume therapy, Dose: 50ml/kg/day

34. Gelatins
 Derived from hydrolyzed bovine collagen
 Metabolized by serum collagenase
 0.5-5hr
Disadvantiges:
 Histamine release (H1 blockers recommended)
 Decreases Von W factor (VWF)
 Bovine Spongiform Encephalopathy
1:1,000.000

35. Albumins
 Heat treated preparation of human serum
5% (50g/l), 25% (250g/l)
 5% is used for volume expansion, Half of infused
volume will stay intravascular
 25% used only in case of hypoalbuminemia

36. Cont. Albumin
Disadvantages:
 Cardiac decompensation after rapid infusion of
20- 25% albumin
 decreased Ionized ca++
 Impaired Na+Water excretion renal
dysfunction

37. Composition
Fluid Osmo-
lality
Na Cl K
D5W 253 0 0 0
0.9NS 308 154 154 0
LR 273 130 109 4.0
Plasma-lyte 294 140 98 5.0
Hespan 310 154 154 0
5% Albumin 308 145 145 0
3%Saline 1027 513 513 0

39. Crystalloids OR Colloids
ACS protocol for ATLS: replace each ml of blood
loss with 3 ml of crystalloid fluid (3 for 1 rule).
Patient response:
 Rapid
 Transient
 Non-responsive

40. Transfusion Therapy
60% of transfusions occur perioperatively.
responsibility of transfusing perioperatively is with the
anesthesiologist.

41. (up to 30% of blood volume can be treated
with crystalloids)
If blood loss exceeds 20% of blood volume and
still there is on going bleeding this will
necessitate blood transfusion.
Blood volume formula
 Neonate - 90 ml/kg
 Infants 2 years ago - 80ml/kg
 Adult male - 70ml/kg
 Adult female - 60ml/kg

42. Blood Transfusion
WHY?
-Improvement of oxygen transport
-Restoration of red cell mass
-Correction of bleeding caused by platelet
dysfunction
-Correction of bleeding caused by factor
deficiencies

43. When is Transfusion Necessary?
• “Transfusion Trigger”: Hgb level at which
transfusion should be given.
- Varies with patients and procedures
• Tolerance of acute anemia depends on:
- Maintenance of intravascular volume
- Ability to increase cardiac output
- Increases in 2,3-DPG to deliver more of the carried
oxygen to tissues

44. Oxygen Delivery
• Oxygen Delivery (DO2) is the oxygen that is
delivered to the tissues
DO2= COP x CaO2
• Cardiac Output (CO) = HR x SV
• Oxygen Content (CaO2):
- (Hgb x 1.39)O2 saturation + PaO2(0.003)
- Hgb is the main determinant of oxygen content in the blood

45. Oxygen Delivery (cont.)
• Therefore: DO2 = HR x SV x CaO2
• If HR or SV are unable to compensate, Hgb is the
major determinant factor in O2 delivery
• Healthy patients have excellent compensatory
mechanisms and can tolerate Hgb levels of 7
gm/dL.
• Compromised patients may require Hgb levels
above 10 gm/dL.

46. Blood Groups
Antigen on Plasma
Blood Group erythrocyte Antibod
A A Anti-B
B B Anti-A
AB AB None
O None Anti-A
Anti-B
Rh Rh

47. Cross Match
• Major:
- Donor’s erythrocytes (packed cells) incubated with
recipients plasma
• Minor:
- Donor’s plasma incubated with recipients erythrocytes
• Agglutination:
- Occurs if either is incompatible
• Type Specific:
- Only ABO-Rh determined; chance of hemolytic reaction is
1:1000 with TS blood

48. Type and Screen
• Donated blood that has been tested for ABO/Rh
antigens and screened for common antibodies (not
mixed with recipient blood).
- Used when usage of blood is unlikely, but needs to be
available (hysterectomy).
- Allows blood to available for other patients.
- Chance of hemolytic reaction: 1:10,000.

49. Blood Components
 Whole blood is separated by differential centrifugation
 Packed Red Blood Cells (pRBC’s)
 Platelets
 Fresh frozen Plasma, Contain all clotting factors
 Cryoprecipitate contain factor VIII and fibrinogen
 Factor VIII
 Albumin
 Others, antibody concentrate, Plasma protein fraction

50. Whole Blood
 Storage
 4° for up to 35 days
 Indications
 Massive Blood Loss/Trauma/Exchange Transfusion
 Considerations
 Use filter .
 Donor and recipient must be ABO identical

51. Packed Red Blood Cells
• 1 unit = 250 ml. Hct. = 70-80%.
• 1 unit pRBC’s raises Hgb 1 gm/dL.
• Mixed with saline: LR has Calcium which may
cause clotting if mixed with pRBC’s.

52. RBC Transfusions
Administration
 Dose
 Usual dose of 10 cc/kg infused over 2-4 hours
 Maximum dose 15-20 cc/kg can be given to hemodynamically stable patient
 Procedure
 Filter use—routinely
 Monitoring
 Do NOT mix with medications
 Complications
 Rapid infusion may result in Pulmonary edema
 Transfusion Reaction

53. Platelet Concentrate
 Storage
 Up to 5 days at 20-24°
 Indications
 Thrombocytopenia, Plt <15,000
 Bleeding and Plt <50,000
 Invasive procedure and Plt <50,000
 Considerations
 Contain Leukocytes and cytokines
 1 unit/10 kg of body weight increases Plt count by 50,000
 Donor and Recipient must be ABO identical

54. Plasma and FFP
 Contents—Coagulation Factors (1 unit/ml)
 Storage
 FFP--12 months at –18 degrees or colder
 Indications
 Coagulation Factor deficiency, fibrinogen replacement, DIC, liver disease,
exchange transfusion, massive transfusion
 Considerations
 Plasma should be recipient RBC ABO compatible
 In children, should also be Rh compatible
 Usual dose is 20 cc/kg to raise coagulation factors approx 20%

55. Transfusion Complications
Hemolytic Reactions (acute or delayed)
Febrile Reactions (FNHTR)
Allergic Reactions
TRALI
Coagulopathy with Massive transfusions
Infection

56. Complications of Blood Therapy
• Hemolytic:
- Wrong blood type administered (oops).
- Activation of complement system leads to intravascular
hemolysis, spontaneous hemorrhage.

57. Complications of Blood Therapy
(cont.)
Signs:
hypotension,
fever, chills
dyspnea, skin flushing,
substernal pain , Back/abdominal pain
Oliguria Dark urine Pallor
Signs are easily masked by general anesthesia.
- Free Hgb in plasma or urine
- Acute renal failure
- Disseminated Intravascular Coagulation (DIC)

58. Complications of Blood Therapy
Cont.
- Febrile; most common, usually controlled by slowing
infusion and giving antipyretics
- Allergic; increased body temp., pruritis, urticaria.
Rx: antihistamine,discontinuation. Examination of
plasma and urine for free hemoglobin helps rule out
hemolytic reactions.

59. Complications (cont.)
• Transmission of Viral Diseases:
- Hepatitis C; 1:30,000 per unit
- Hepatitis B; 1:200,000 per unit
- HIV; 1:450,000-1:600,000 per unit
- 22 day window for HIV infection and test detection
- CMV may be the most common agent transmitted, but
only effects immuno-compromised patients
- Parasitic and bacterial transmission very low

60. Other Complications
- Decreased 2,3-DPG with storage: ? Significance
- Citrate: metabolism to bicarbonate; Calcium binding
- Microaggregates (platelets, leukocytes): micropore
filters controversial
- Hypothermia: warmers used to prevent
- Coagulation disorders: massive transfusion (>10 units)
may lead to dilution of platelets and factor V and VIII.
- DIC: uncontrolled activation of coagulation system

61. What to do?
If an AHTR occurs
 STOP TRANSFUSION
 ABC’s
 Maintain IV access and run IVF (NS or LR)
 Monitor and maintain BP/pulse
 Give diuretic
 Obtain blood and urine for transfusion reaction workup
 Send remaining blood back to Blood Bank

62. Blood Bank Work-up of AHTR
Check paperwork to assure no errors
Check plasma for hemoglobin
Repeat crossmatch
Repeat Blood group typing
Blood culture

63. Monitoring in AHTR
Monitor patient clinical status and vital signs
Monitor renal status (BUN, creatinine)
Monitor coagulation status (DIC panel– PT/PTT,
fibrinogen, D-dimer/FDP, Plt, Antithrombin-III)
Monitor for signs of hemolysis (LDH, bili,
haptoglobin)

64. Massive Blood Transfusion
Massive transfusion is generally defined as the
need to transfuse one to two times the patient's
blood volume. For most adult patients, that is the
equivalent of 10–20 units

65. Massive Blood Transfusion
Coagulopathy due to dilutional thrombocytopenia.
And dilution of the coagulation factors
Citrate Toxicity does not occur in most normal
patients unless the transfusion rate exceeds 1 U
every 5 min
Hypothermia
Acid–Base Balance The most consistent acid–
base abnormality after massive blood transfusion
is postoperative metabolic alkalosis

66. Serum Potassium Concentration increase
The extracellular concentration of potassium in
stored blood steadily increases with time
Hypokalemia is commonly encountered
postoperatively, particularly in association with
metabolic alkalosis

67. Administering Blood Products
- Consent necessary for elective transfusion
- Unit is checked by 2 people for Unit #, patient ID,
expiration date.
- pRBC’s are mixed with saline solution (not LR)
- Products are warmed mechanically and given slowly if
condition permits
- Close observation of patient for signs of complications
- If complications suspected, infusion discontinued,
blood bank notified, proper steps taken.

68. Autologous Blood
• Pre-donation of patient’s own blood prior to
elective surgery
• 1 unit donated every 4 days (up to 3 units)
• Last unit donated at least 72 hrs prior to surgery
• Reduces chance of hemolytic reactions and
transmission of blood-bourne diseases
• Not desirable for compromised patients

69. Autotransfusion
• Commonly known as “Cell-saver”
• Allows collection of blood during surgery for re-
administration
• RBC’s centrifuged from plasma
• Effective when > 1000ml are collected

70. THANK YOU